Hasil Pencarian - Farhad Ravandi

Perbaiki Hasil
  1. 1
    Therapy-related acute promyelocytic leukemia

    Therapy-related acute promyelocytic leukemia oleh Farhad Ravandi

    Diterbitkan 2011-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Can measurable residual disease assessment be reliably used to defer allogeneic stem cell transplant in patients with intermediate-risk acute myeloid leukemia?

    Can measurable residual disease assessment be reliably used to defer allogeneic stem cell transplant in patients with intermediate-risk acute myeloid leukemia? oleh Mahesh Swaminathan, Farhad Ravandi

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?

    How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia? oleh Nicholas J. Short, Farhad Ravandi

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm

    FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm oleh Naval Daver, Sangeetha Venugopal, Farhad Ravandi

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Acute promyelocytic leukemia current treatment algorithms

    Acute promyelocytic leukemia current treatment algorithms oleh Musa Yilmaz, Hagop Kantarjian, Farhad Ravandi

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Maintenance therapy in acute myeloid leukemia: advances and controversies

    Maintenance therapy in acute myeloid leukemia: advances and controversies oleh Jayastu Senapati, Tapan M. Kadia, Farhad Ravandi

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Editorial: Acute Promyelocytic Leukemia — Towards A Chemotherapy-Free Approach to Cure in All Patients

    Editorial: Acute Promyelocytic Leukemia — Towards A Chemotherapy-Free Approach to Cure in All Patients oleh Harinder Gill, Yok-Lam Kwong, Farhad Ravandi

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors

    Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors oleh Nicholas J. Short, Daniel Nguyen, Farhad Ravandi

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Evaluating measurable residual disease in acute myeloid leukemia

    Evaluating measurable residual disease in acute myeloid leukemia oleh Farhad Ravandi, Roland B. Walter, Sylvie D. Freeman

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia

    Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia oleh Nicholas J. Short, Hagop Kantarjian, Farhad Ravandi, Naval Daver

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia

    The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia oleh Robert Briski, Guillermo Garcia-Manero, Hagop Kantarjian, Farhad Ravandi

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions

    Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions oleh Bachar Samra, Elias Jabbour, Farhad Ravandi, Hagop Kantarjian, Nicholas J. Short

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia

    Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia oleh Marisa J. L. Aitken, Farhad Ravandi, Keyur P. Patel, Nicholas J. Short

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    90552 Evidence synthesis with reconstructed survival data

    90552 Evidence synthesis with reconstructed survival data oleh Chenqi Fu, Shouhao Zhou, Nicholas Short, Xuelin Huang, Donald Berry, Farhad Ravandi-Kashani

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Relapse and death during first remission in acute myeloid leukemia

    Relapse and death during first remission in acute myeloid leukemia oleh Masamitsu Yanada, Guillermo Garcia-Manero, Gautam Borthakur, Farhad Ravandi, Hagop Kantarjian, Elihu Estey

    Diterbitkan 2008-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia

    Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia oleh Veronica A. Guerra, Elias J. Jabbour, Farhad Ravandi, Hagop Kantarjian, Nicholas J. Short

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia

    Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia oleh Masamitsu Yanada, Gautam Borthakur, Farhad Ravandi, Carlos Bueso-Ramos, Hagop Kantarjian, Elihu Estey

    Diterbitkan 2008-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Resistance to targeted therapies: delving into FLT3 and IDH

    Resistance to targeted therapies: delving into FLT3 and IDH oleh Sai Prasad Desikan, Naval Daver, Courtney DiNardo, Tapan Kadia, Marina Konopleva, Farhad Ravandi

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades

    The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades oleh Elias Jabbour, Nicholas J. Short, Nitin Jain, Fadi G. Haddad, Mary Alma Welch, Farhad Ravandi, Hagop Kantarjian

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia

    Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia oleh Aram Bidikian, Hagop Kantarjian, Elias Jabbour, Nicholas J. Short, Keyur Patel, Farhad Ravandi, Koji Sasaki, Ghayas C. Issa

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: